| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -16,276 | 68,161 | -24,942 | -28,909 |
| Depreciation and amortization | 1,999 | 2,075 | 2,183 | 4,119 |
| Non-cash stock-based compensation expense | 1,168 | 2,256 | 2,162 | 4,159 |
| Impairment of fixed assets | NaN | 0 | 2,275 | NaN |
| Loss on sale of assets | 0 | -11 | -16 | -177 |
| Gain on disposal of business | NaN | 81,655 | NaN | NaN |
| Deferred income taxes | NaN | 0 | 0 | 0 |
| Net losses on investment securities | -40 | -31 | 1,359 | -102 |
| Equity in earnings from equity-method investments | 388 | 9 | -23 | 201 |
| Non-cash interest expense | 0 | 186 | 702 | 1,311 |
| Non-cash lease expense | 4,590 | 4,711 | 4,747 | 9,779 |
| Change in fair value of the derivative embedded within convertible debt | 0 | 4,678 | -15,445 | -17,715 |
| Provision for credit losses | 867 | 675 | 1,368 | 2,358 |
| Loss on extinguishment of liability | NaN | -466 | NaN | NaN |
| Receivables | 4,437 | 2,033 | -3,651 | 5,513 |
| Income taxes payable, net | 1,152 | -3,549 | 70 | -81 |
| Contract assets, net | 4,870 | 2,719 | 206 | 4,527 |
| Operating lease liabilities | -5,080 | -5,480 | -5,482 | -11,246 |
| Antitrust litigation settlement | NaN | -5,000 | 0 | 0 |
| Accounts payable | 11,642 | -3,333 | -1,619 | 6,486 |
| Other assets and liabilities | 7,110 | -3,294 | -1,651 | 5,298 |
| Accrued salaries and benefits | -7,879 | 4,366 | 3,690 | -2,501 |
| Contract liabilities | 7,544 | 743 | 1,245 | 6,933 |
| Net cash used in operating activities | -19,342 | -14,383 | 5,480 | -4,975 |
| Purchase of debt securities | NaN | 0 | NaN | NaN |
| Purchase of equity securities | NaN | 0 | NaN | NaN |
| Proceeds from sale or liquidation of long-term investments | 28 | 43 | 1,533 | 78 |
| Proceeds from sale or liquidation of short-term investments | 0 | 0 | 0 | 97,677 |
| Purchase of short-term investments | 0 | 0 | 0 | 87,873 |
| Purchase of investment securities at fair value | NaN | 0 | NaN | NaN |
| Proceeds from disposal of business, less cash distributed | NaN | 82,494 | NaN | NaN |
| Purchase of long-term investments | 60 | 30 | 25 | 83 |
| Capital expenditures | 259 | 312 | 790 | 2,251 |
| Purchase of subsidiaries | 100 | NaN | NaN | NaN |
| Net cash (used in) provided by investing activities | -391 | 82,195 | 718 | 7,548 |
| Proceeds from debt issuance | NaN | 0 | 0 | NaN |
| Repayments of convertible note | NaN | 94,067 | NaN | NaN |
| Deferred financing charges | NaN | 0 | 0 | NaN |
| Withholding of shares as payment of payroll tax liabilities in connection with restricted stock vesting | NaN | 1,943 | 0 | 85 |
| Dividends on common stock | NaN | 0 | NaN | NaN |
| Net cash (used in) provided by financing activities | NaN | -96,010 | 0 | -85 |
| Net (decrease) increase in cash, cash equivalents and restricted cash | -19,733 | -28,198 | 6,198 | 2,488 |
| Cash, cash equivalents and restricted cash, beginning of period | 122,709 | 150,907 | 142,221 | NaN |
| Cash, cash equivalents and restricted cash, end of period | 102,976 | 122,709 | 150,907 | NaN |
Douglas Elliman Inc. (DOUG)
Douglas Elliman Inc. (DOUG)